Skip to main content

Not investment advice.Read full disclaimer

Healthcare · Biotechnology

52W Range

5thpctl

Volume

0.11×avg

Market Cap

2.07MUSD

P/E Ratio

-0.4TTM

Div Yield

-ann

Continue with finqOS

Explore Adial Pharmaceuticals, Inc.'s financials

Income statements, balance sheets, and cash flows - annual and quarterly, going back 20+ years.

Start Free Trial→Sign In

14-day free trial · No credit card required

Adial Pharmaceuticals, Inc.

ADILNASDAQ Capital Market·USD·Closed

Adial Pharmaceuticals, Inc.

ADILNASDAQ·USD·Closed

$2.16

+1.41%

$2.16

+$0.03 (1.41%)

52W Range

5thpctl

Volume

0.11×avg

Mkt Cap

2.07MUSD

P/E

-0.4TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

ADIL: Adial Pharmaceuticals, Inc. Financial Statements & Revenue | finqOS